http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016146812-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e0db8a6ad24e2cb1eba78ebf4dffcd |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92770155f41fd5f30e1f0ed8bfa6e289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a600466a41f5a9fed8d0338d01fcf31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_847d1b9c09b573839aea20ef54d45f7d |
publicationDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2016146812-A1 |
titleOfInvention | Method of detecting and identifying circulating antigens in human biological samples |
abstract | Disclosed herein is a method of detecting and identifying antigens that are shed into human bodily fluids during infection. The disclosed method allows circulating antigens associated with a particular infection to be detected within minutes or hours from testing as compared to days required with the current methods. Methods of identifying diagnostic indicators/targets for a given condition or disease are disclosed which include immunizing a verterinary subject with biological fluids obtained from a human infected with particular antigens to identify diagnostic targets for immunoassay. Also disclosed are methods of diagnosing and monitoring a B. pseudomallei -associated condition, such as melioidosis. Point-of-care immunoassays are also provided that can be used to diagnose or monitor the efficacy of a B. pseudomallei -associated condition treatment. These immunoassays can also be used for rapid diagnosis of infection produced by B. pseudomallei , such as meliodosis. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740234-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020362385-A1 |
priorityDate | 2012-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1057.